Site-specific Cancer Nanotheranostics

Nanoparticles and Tumor microenvironment: challenges and opportunities
Materials and chemistries of tumor microenvironment-responsive delivery platforms
pH-responsive delivery nanoplatform in cancer theranostics
Enzyme-responsive delivery nanoplatform in cancer theranostics
Redox-responsive delivery nanoplatform in cancer theranostics
ROS-responsive delivery nanoplatform in cancer theranostics
Hypoxia-responsive delivery nanoplatform in cancer theranostics
Dual/multi-responsive delivery nanoplatforms in cancer theranostics
Temperature-responsive delivery nanoplatform in cancer theranostics
Light-responsive delivery nanoplatform in cancer theranostics
Magnetic field-responsive delivery nanoplatform in cancer theranostics
Ultrasound-responsive delivery nanoplatform in cancer theranostics
Exogenous dual/multi-responsive delivery platforms in cancer theranostics
Aptamer-based targeting of nanoplatforms for cancer theranostics
Peptide-based targeting of nanoplatforms for cancer theranostics
Antibody-based targeting of nanoplatforms for cancer theranostics
Carbohydrate-based targeting of nanoplatforms for cancer theranostics
Subcellular targeting of nanoparticles for cancer theranostics
Characterization techniques for stimuli-responsive delivery nanoplatforms in cancer treatment
Toxicological aspects of tumor microenvironment-responsive nanoplatforms
Commercialization challenges of tumor microenvironment-responsive nanoplatforms

Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.

• Nanotecnologia
• Oncologia
• Farmacologia
• Tecnologia farmacêutica

Cancer theranostics;Endogenous and exogenous stimuli-responsive nanoplatforms;Targeting materials and strategies in cancer therapy;Nanoparticles and tumor microenvironment;Nanomedicine;Cell environment-inspired therapeutic strategies;Tumour Microenvironment;Drug Release;Mesoporous Silica NPs;Theranostic Nanoplatform;Delivery Systems;Stimuli Responsive Drug Delivery Systems;Drug Delivery Systems;Iron Oxide Nanoparticles;PTT;Drug Delivery;SDT;Cancer Cells;SPIONs;pH Responsive DDS;Stimuli Responsive Systems;Theranostic Agents;Magnetic Nanoparticles;Hyaluronic Acid;Acidic TME;Theranostic Nanomedicine;Theranostic Nanoparticles;Stimuli Responsive Drug Delivery;BBR;Target Cancer Cells